Aadi Bioscience, Inc. (AADI)
Chart Events
Performance Outlook
| Previous Close | 13.88 |
| Open | 13.97 |
| Bid | 13.33 x 1000 |
| Ask | 13.39 x 1000 |
| Day's Range | 13.30 - 14.15 |
| 52 Week Range | 11.00 - 40.20 |
| Volume | |
| Avg. Volume | 148,758 |
| Market Cap | 278.726M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.90 |
| Earnings Date | Mar 09, 2022 - Mar 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 43.50 |
- PR Newswire
Aadi Bioscience Announces Financial Results for the Second Quarter of 2022 and Provides Corporate Update
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today provided a corporate update and announced financial results for the second quarter of 2022.
- Simply Wall St.
Is Aadi Bioscience, Inc. (NASDAQ:AADI) Popular Amongst Insiders?
Every investor in Aadi Bioscience, Inc. ( NASDAQ:AADI ) should be aware of the most powerful shareholder groups...
- PR Newswire
Aadi Bioscience to Report Second Quarter 2022 Results and Corporate Update
Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced that it will host a conference call and live webcast on Wednesday, August 10, 2022 at 8:30 am EDT (5:30 am PDT) to report second quarter 2022 financial results and provide recent corporate updates.
